Another study indicated that the combination of berberine with emodin synergistically inhibited breast cancer cell growth via inhibiting salt-inducible kinases 3 (SIK3) activity and induced G0/G1 phase cell cycle arrest and apoptosis of breast cancer cells by attenuating Akt signaling [39]. Here, AKT1 is linked to breast carcinoma.